Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000124

Director sold 100 shares at an average $1,178.69 ($117,869)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RYAN ARTHUR F · Director

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-03 Sale : show line 1 in the form 10b5-1 −4 $1,166.52 $4,666 17,778 D
2024-09-03 Sale : show line 2 in the form 10b5-1 −1 $1,167.27 $1,167 17,777 D
2024-09-03 Sale : show line 3 in the form 10b5-1 −4 $1,168.99 $4,676 17,773 D
2024-09-03 Sale : show line 4 in the form 10b5-1 −4 $1,170.40 $4,682 17,769 D
2024-09-03 Sale : show line 5 in the form 10b5-1 −16 $1,172.75 $18,764 17,753 D
2024-09-03 Sale : show line 6 in the form 10b5-1 −8 $1,174.32 $9,395 17,745 D
2024-09-03 Sale : show line 7 in the form 10b5-1 −8 $1,175.66 $9,405 17,737 D
2024-09-03 Sale : show line 8 in the form 10b5-1 −4 $1,176.82 $4,707 17,733 D
Open-market sales · 100 sh · avg $1,178.69 · $117,869
Loading xslF345X05/edgardoc.xml…